Pharmacophore elucidation and docking studies on anti-inflammatory compounds of medicinal plants for Ulcerative Colitis

Asian Journal of Pharmaceutical and Clinical Research

Volumn 6, Issue SUPPL.3, 2013, Pages 56-61

  Hamsa, N S ^a   Nair, Vandana P ^a   Chandramohan, Vivek ^b   Patel, Seema J ^a  

^a GM INSTITUTE OF TECHNOLOGY   (India)

^b SIDDAGANGA INSTITUTE OF TECHNOLOGY   (India)

Author keywords

Glucocorticoid; Inflammatory bowel disease; NF kB p50 p65; TOPKAT; ZDOCK

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFLAMMATORY AGENT; BILOBETIN; BOWDICHIONE; GINKGETIN; GLUCOCORTICOID RECEPTOR; HERBACEOUS AGENT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESUAXANTHONE B; PICEN 13 OL; PROTEIN P50; SYNAPTOTAGMIN I; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; COMPUTER PROGRAM; CRYSTAL STRUCTURE; CYTOTOXICITY; DISEASE SEVERITY; DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG METABOLISM; DRUG TARGETING; FEMALE; MEDICINAL PLANT; MOLECULAR DOCKING; NONHUMAN; PHARMACOPHORE; PROTEIN TARGETING; RAT; ULCERATIVE COLITIS;

EID: 84883433001     PISSN: 09742441     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Lu SY, Jiang YJ, Lv J, Wu TX QS and Zhu WL: Molecular docking and molecular dynamics simulation studies of GPR40 receptor-agonist interactions. J Mol Graph Model 2010; 28: 766-774.
2. Rong Chen, Li Liand Zhiping Weng, ZDOCK: An Initial-Stage Protein Docking Algorithm. PROTEINS: Structure, Function and Genetics 2003; 52:80-87.
3. http://pubchem.ncbi.nlm.nih.gov/
4. www. Chemicalize.org
5. Lipinski CA, Franco I, Dominy BW, Feeney PJ: Experimental and computational approaches to estímate solubility and permeability in drug discovery and development settings. Advance Drug Delivery Review 1997; 23:3-25.
6. D Jayasimha Rayalu, D Muralidhara rao and D S Rao: Phytochemical screening and insilico approach for the identification of anti-stress compounds from medicinal plants. 2013; 4:324-334.
7. Daisy P, Suveena S: Solutions to pharmaceutical issues for anti-cancer drugs by accord excel. Asian journal of pharmaceutical and clinical research 2012; 5:149-158.
8. Rarey M, Kramer B, Lengauer T, Klebe G: A Fast Flexible Docking Method using an Incremental Construction Algorithm. Journal of Molecular Biology 1996; 261:470-489.
9. G Jones, P Wilett, R C Glen, A R Leach, R Taylor: Development and validation of a genetic algorithm for flexible docking. Journal of molecular Biology 1997; 267:727-748.
10. Vidyanath Chaudhary: Structure based inhibitor designing for Rac-alphaserine/threonine-proteinkinase in human. Journal of Advanced Bioinformatics Applications and Research 2012; 3:374-378.
11. Momany FA, Rone RJ. Validation of the general purpose QUANTA 3.2/CHARMm force field. Comp chem 1992; 13:888-900.
12. Van de Waterbeemd H, Gifford E. ADMET Insilico Modelling. Towards prediction Paradise? Nat Rev Drug Discovery 2003; 2:192-204.
13. CHS Venkataramana, KM Ramya Sravani, S Swetha Singh and V Madhavan. Insilico ADME and toxicity studies of some novel indole derivatives, Journal of Applied Pharmaceutical Science 2011; 1:159-162.
14. Wolber G, Kosara R, Pharmacophores from macromolecular complexes with Ligand Scout. In Pharmacophores and Pharmacophore Searches Edited by: Langer T, Hoffmann RD 2006; 32:131-150.
15. Wolber G, Seidel T, Bendix F, Langer T, Molecule-pharmacophore superpositioning and pattern matching in computational drug design. Drug Discovery Today 2008; 13: 23-29.
16. Lavalle SM, Finn PW, Kavraki LE, Latombe J C, A Randomized Kinematics-Based Approach to Pharmacophore-Constrained Conformational Search and Database Screening. J Comput Chem 2000; 21:731-747.